Sun.Apr 21, 2024

article thumbnail

USDA releases H5N1 bird flu genetic data eagerly awaited by scientists

STAT

The U.S. Department of Agriculture, which has been under pressure from scientists both at home and abroad to share more data on the H5N1 bird flu outbreaks in dairy cows, uploaded a large number of genetic sequences of the pathogen late Sunday. Access to the 239 genetic sequences will help scientists assess whether the dangerous virus has acquired mutations that might make it easier for it to spread to and among mammals, and whether additional changes have been seen as it moves from cow to cow a

363
363
article thumbnail

New patent expiration for Galderma Labs drug SOOLANTRA

Drug Patent Watch

Annual Drug Patent Expirations for SOOLANTRA Soolantra is a drug marketed by Galderma Labs Lp and is included in one NDA. It is available from three suppliers.

105
105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Opinion: Public health during Sudan’s civil war: nurturing resilience amid conflict

STAT

On a Friday morning one year ago this week, my colleagues in Sudan’s Ministry of Health and I met for the relatively routine business of endorsing a plan to deal with looming epidemics of cholera, dengue fever, and measles. The next morning, my family and I awoke to gunfire in the streets of the capital, Khartoum; we lived near the headquarters of the Army General Command, where the fighting began, and heard the sound of jet fighters bombing the airport and other targets.

Hospitals 238
article thumbnail

CSL Vifor offers campaign to mollify EC in antitrust probe

pharmaphorum

CSL Vifor offers a communication campaign to answer EU allegations it disparaged a rival iron deficiency treatment from Pharmacosmos.

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

People with MND in England and Wales fear losing access to life-extending drug

The Guardian - Pharmaceutical Industry

Exclusive: NHS cost threshold has not been raised by National Institute for Health and Care Excellence since 2004 People with motor neurone disease have spoken of their devastation at a likely loss of access to a life-extending drug due to an NHS cost threshold that has not been raised since 2004. Tofersen has slowed the progress of the illness in trials but the chances of the drug being recommended for use in England and Wales are said to be slim.

82
article thumbnail

Astellas’ generic Myrbetriq defence knocked back again

pharmaphorum

Generics of Astellas’ Myrbetriq for urinary incontinence are looming in the US after a court recommended against an injunction on copycats from Zydus and Lupin

83

More Trending

article thumbnail

“Heigh-ho” Taiho! The PTO Says LYTGOBI Patent is Ineligible for PTE Because of Untimely Application. And a Corrected NDA Approval Letter is No Saving Grace

FDA Law Blog: Biosimilars

By Kurt R. Karst — If you’ve been following this blog since the early days, then you know we fervently followed the more-than-decade-long soap opera that was The Medicines Company’s efforts to obtain a Patent Term Extension (“PTE”) from the U.S. Patent and Trademark Office (“PTO”) for U.S. Patent No. 5,196,404 covering ANGIOMAX (bivalirudin) after the company’s patent counsel untimely filed for a PTE 62 days after the ANGIOMAX NDA 020873 approval at 5:18 PM on Friday, December 15, 2000 (see our

article thumbnail

Episode 915: The rare case when a very hypotonic solution may be indicated

Pharmacy Joe

In this episode, I’ll discuss the rare case when a very hypotonic solution may be indicated. Episode 915: The rare case when a very hypotonic solution may be indicated Subscribe on iTunes , Android , or Stitcher A recent commentary published in AJHP argues for abandoning the use of extremely hypo-osmolar intravenous solutions to treat hypernatremia.

article thumbnail

How to Choose Your Right Pharmacy

Pharma Mirror

An article by Aloiz Kara Aging represents a risk factor for many health problems and diseases, which means that as we grow older, there is a high probability that our health will change negatively. While some of those health issues could be attributed to a hectic lifestyle, the same way of living could keep you from getting the necessary prescribed medicine.

52
article thumbnail

New patent expiration for Endo Pharms drug MEGACE ES

Drug Patent Watch

Annual Drug Patent Expirations for MEGACE+ES Megace Es is a drug marketed by Endo Pharms Inc and is included in one NDA.

59
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Exploring Periodontal Disease: Present Therapies, Emerging Treatments, and Beyond

Pharma Mirror

Periodontal Disease (PD) is a severe, progressive gum infection that targets the gums, inflaming and damaging the soft tissue and supporting bone around the teeth. PD is caused by pathogenic microflora in the biofilm that forms below the gum line adjacent to the teeth. The infection begins as gingivitis, which leads to periodontitis, causing the gums to recede and eventually destroy the bone supporting the teeth causing the teeth to loosen.

52
article thumbnail

Practical Considerations of T-Cell Engagers in the Management of Relapsed/Refractory Multiple Myeloma

Pharmacy Times

Integration of these agents requires supportive care considerations for cytokine release syndrome, neurotoxicity, infection, and antigen-specific toxicities to ensure optimal care of patients with multiple myeloma receiving T-cell–engaging therapies.

49
article thumbnail

Virtual Hospital Waiting Room: Usefulness and Development Steps

Pharma Mirror

The healthcare industry is actively digitalizing and employing modern tools to enrich the grade of service. Clinics incorporate virtual waiting rooms, among other software, to boost patient care and improve staff workflow in traditional medical establishments. In this guide, we’ll investigate the advantages of virtual hospital waiting rooms and how they are revolutionizing healthcare.

article thumbnail

Sartorius In-Line Lysis System: The Easiest Alternative to Batch Alkaline Lysis

PharmaTech

Webinar Date/Time: Tue, Jun 11, 2024 10:00 AM EDT

52
article thumbnail

Internet of Things (IoT) in Healthcare Market to be Worth USD 648.94 Billion by 2031

Pharma Mirror

The healthcare landscape is rapidly transforming, fueled by the convergence of technology and medicine. Among the myriad of innovations, the Internet of Things (IoT) stands out as a beacon of hope, promising to revolutionize patient care, streamline operations, and enhance medical outcomes. As we delve into the IoT in Healthcare Market Outlook for 2031, the data paints a vivid picture of an industry poised for unprecedented growth and innovation.

52
article thumbnail

New tentative approval for Xiamen Lp drug topiramate

Drug Patent Watch

[!

59
article thumbnail

General Design Methods for mRNA Drugs

Pharma Mirror

With the rapid development of biotechnology and molecular medicine, the introduction of mRNA as a vaccine or therapeutic agent enables the production of almost any desired functional protein/peptide within the human body. This represents an increasingly promising field of precision medicine, holding significant prospects for preventing and treating numerous challenging or genetic diseases.

article thumbnail

Which pharmaceutical companies have the most syrup dosed drugs?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most syrup dosed drugs. For a different perspective, see the most popular dosage types.